| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/14/2004 | CN1468246A Hydroxyesters of 7-desmethylrapamycin |
| 01/14/2004 | CN1468241A Heterocyclic compounds as ligands of the gabaa receptor |
| 01/14/2004 | CN1468233A Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468226A Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 01/14/2004 | CN1468225A 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 01/14/2004 | CN1468224A Derivatives of quinoline as alpha-2 antagonists |
| 01/14/2004 | CN1468222A N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3 receptor antagonists |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468219A Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 01/14/2004 | CN1468209A Stable salts of o-acetylsalicyclic with basic amino acids |
| 01/14/2004 | CN1468123A Method and composition for altering a b cell mediated pathology |
| 01/14/2004 | CN1468111A A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
| 01/14/2004 | CN1468101A Method for reducing or stopping smoking |
| 01/14/2004 | CN1468100A Pharmaceutical compositions and methods for use |
| 01/14/2004 | CN1468097A Compositions comprising modafinil compounds |
| 01/14/2004 | CN1468096A Pharmaceutical solutions of modafinil compounds |
| 01/14/2004 | CN1468090A Slow release pharmaceutical preparation and method of administering same |
| 01/14/2004 | CN1466948A Medicine for getting good sleep |
| 01/14/2004 | CN1134442C Pyrazolopyrimidinone cGMPPDE 5 inhibitors, method for preparing the same and uses and intermediate |
| 01/14/2004 | CN1134440C 4-oxo-3,5-dihydro-4H-pyridazino [4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy |
| 01/14/2004 | CN1134420C Novel substituted imidazole compounds |
| 01/14/2004 | CN1134418C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/14/2004 | CN1134417C 3-phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 01/14/2004 | CN1134259C Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperdines)-butylazols in preparation of a medicament for the treatment of pain |
| 01/14/2004 | CN1134256C Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration. |
| 01/14/2004 | CN1134253C Oral slow-releasing opioid formulations and method for preparing the same |
| 01/13/2004 | US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 01/13/2004 | US6677376 Complexes comprising rotamase inhibitors and cyclophilins, administered for prevention of neurodegenarative diseases such as parkinson's or alzheimer's disease |
| 01/13/2004 | US6677374 Nervous system disorders |
| 01/13/2004 | US6677373 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5H-furan-2-one |
| 01/13/2004 | US6677359 N-substituted glycine derivatives |
| 01/13/2004 | US6677357 Nerve growth factor; animal growth regulator; antitmor agent |
| 01/13/2004 | US6677355 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677351 Useful in treatment of asthma and inflammation |
| 01/13/2004 | US6677346 Methods comprising intranasal morphine |
| 01/13/2004 | US6677340 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/13/2004 | US6677339 S-3-(4-(3,5-dichloropyrid-4-ylcarboxamido)phenyl)-2-(4,6-dimet hoxy-1,3,5-triazin-2-ylamino)propanoic acid for example; inhibit binding of alpha 4 integrins to their ligands, for treating immune or inflammatory disorders |
| 01/13/2004 | US6677338 Serotonin transport inhibitors |
| 01/13/2004 | US6677330 Acetylcholinesterase inhibitors; treating alzheimer*s disease, attention deficit, hyperactivity and brain disorders |
| 01/13/2004 | US6677316 Adenosine derivatives and methods of administration |
| 01/13/2004 | US6677305 Insulin-like growth factor agonist molecules |
| 01/13/2004 | US6677116 Methods for treating cancer by modulating β-catenin mediated gene expression |
| 01/13/2004 | US6676959 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption |
| 01/13/2004 | US6676926 Radiopharmaceuticals for diagnosing Alzheimer's disease |
| 01/13/2004 | CA2076664C Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 01/08/2004 | WO2004003235A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | WO2004003164A2 Methods of organ regeneration |
| 01/08/2004 | WO2004003145A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/08/2004 | WO2004002987A1 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 01/08/2004 | WO2004002986A2 Novel benzimidazole derivatives |
| 01/08/2004 | WO2004002983A2 Therapeutic piperazine derivatives useful for treating pain |
| 01/08/2004 | WO2004002961A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | WO2004002960A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | WO2004002533A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | WO2004002532A1 Mkk7 activation inhibitor |
| 01/08/2004 | WO2004002531A1 Remedies for diseases caused by vascular contraction or dilation |
| 01/08/2004 | WO2004002507A1 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases |
| 01/08/2004 | WO2004002500A1 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 01/08/2004 | WO2004002492A1 Use of vasopeptidase inhibitors in the treatment of nephropathy |
| 01/08/2004 | WO2004002488A1 Therapeutic agent for brain hemorrhage |
| 01/08/2004 | WO2004002484A1 Phosphodiesterase inhibitor |
| 01/08/2004 | WO2004002483A1 Substituted 3- and 4- aminomethylpiperidines for use as beta-secretase in the treatment of alzheimer’s disease |
| 01/08/2004 | WO2004002478A1 Methods for treating alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere |
| 01/08/2004 | WO2004002477A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 01/08/2004 | WO2004002463A2 Method of promoting smoking cessation |
| 01/08/2004 | WO2004002462A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 01/08/2004 | WO2004002447A2 Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002421A2 Method for the treatment of multiple sclerosis |
| 01/08/2004 | WO2004002420A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | WO2004002418A2 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | WO2004002402A2 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 01/08/2004 | WO2003091387A3 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 01/08/2004 | WO2003090665A3 Regulation of erythrocyte apoptosis |
| 01/08/2004 | WO2003087174A3 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/08/2004 | WO2003087139A3 Treatment of gastroparesis |
| 01/08/2004 | WO2003087035A8 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor |
| 01/08/2004 | WO2003086315A3 Tyrosine kinase inhibitors |
| 01/08/2004 | WO2003075850A3 Methods for alzheimer's disease treatment and cognitive enhancement |
| 01/08/2004 | WO2003070969A3 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/08/2004 | WO2003070166A3 Novel tyloindicines and related processes, pharmaceutical compositions and methods |
| 01/08/2004 | WO2003068812A3 Immune-modulating peptide made of s. aureus enterotoxin b |
| 01/08/2004 | WO2003063766A3 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/08/2004 | WO2003047618A3 Immunotherapeutic methods and systems |
| 01/08/2004 | WO2003030899A3 Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders |
| 01/08/2004 | WO2003020257A3 USE OF β-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002103016B1 Human tachykinin-related splice variants and compositions thereof |
| 01/08/2004 | WO2002099036A3 Inhibition of neurodegeneration |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002092075A3 Therapeutic delivery of carbon monoxide |
| 01/08/2004 | WO2002080952A3 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002062372A3 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 01/08/2004 | WO2002059124A3 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 01/08/2004 | WO2002056745A3 Method of treating parkinson's disease |